KG LEGAL \ INFO
BLOG

KG Legal publishes an article about clinical trial contract in the one of the most important Polish biotechnological magazine

cover of quarterly biotechnologia.plKG Legal publishes in the second issue of the quarterly “Biotechnologia.pl” an article about contract for clinical trials with a foreign entity.

You can read the article HERE.

More

Liquidation procedure of a branch of a foreign entrepreneur in Poland

Liquidation of a branch of a foreign entrepreneur is proceeded on the basis of the provisions of liquidation contained in the Commercial Companies Code. The first step is to proceed with the entry procedure for the opening of liquidation, when the name of the company is expanded by the phrase ‘in liquidation’. At this stage, the most diligent part is to show the representation before the National Court Register and collect all statutory documents of the parent company. Next, financial documents should be collected in accordance with the Accountancy Act, as the procedure affects the financial period and liquidation settlements and furthermore, the announcement in Court and Economic Journal (Monitor Sądowy i Gospodarczy) needs to be published in order to call creditors to file their claims against the company. The last phase is the deletion of the entity from the National Court Register.

More

KG Legal publishes an article about the amendment of the innovation law in the one of the most important Polish biotechnological magazines

cover of biotechnologia.plKG Legal publishes in the first issue of the quarterly “Biotechnologia.pl” an article about „Small” legal act – new law and tax benefits for biotechnology in Poland.

You can read the article HERE.

More

Medtec Ireland 2017

logo medtec ireland

On the 4-5th October 2017 in Galway, Ireland, there will be held Medtec Ireland 2017, which is one of the older Medical Technology Confex in Europe.

           

 

More

KG Legal conducts networking for Scandinavian firm

KG Legal, as a Polish law firm, is looking for partners and investors for Scandinavian firm producing surgery devices.

The cross border cooperation will be based upon exchange of know-how or technology transfer and  receiving funds from investors.

More

UP